SCHEMBL1775211

SCHEMBL1775211

O=P(O)(O)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 1/20 0.46
MMP14 P50281 1/20 0.46
CA14 Q9ULX7 1/20 0.46
FDPS P14324 1/20 0.44
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP3 P08254 1/20 0.43
HSD17B10 Q99714 2/20 0.42
CA2 P00918 1/20 0.42
CA4 P22748 1/20 0.42
CA5A P35218 1/20 0.42
TSHR P16473 2/20 0.41
PGK1 P00558 3/20 0.41
PGK2 P07205 3/20 0.41
AHR P35869 1/20 0.40
TP53 P04637 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
MAPK1 P28482 1/20 0.39
EPHX1 P07099 1/20 0.39
EPHX2 P34913 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2669738 0.80 CYP3A4 (0.43) CA2CA4CA5ATSHRPGK1
SCHEMBL11039147 0.80 CA2 (0.48) CA14MMP1MMP2MMP3CA2
SCHEMBL11126584 0.78 MMP8 (0.42) MMP8MMP14CA14FDPSHSD17B10
SCHEMBL11099455 0.76 AHR (0.40) MMP8MMP14CA14FDPSMMP1
SCHEMBL11604324 0.76 HPGD (0.46) MMP8MMP14CA14FDPSMMP1
SCHEMBL10931270 0.76 HSD17B10 (0.42) MMP8MMP14CA14FDPSHSD17B10
SCHEMBL11238454 0.75 HPGD (0.43) FDPSMMP1MMP2MMP3HSD17B10
SCHEMBL8649790 0.74 VCAM1 (0.54) HSD17B10TDP1KMT2AKDM4EMEN1
SCHEMBL11777105 0.74 FDPS (0.44) MMP8MMP14CA14FDPSTSHR
SCHEMBL2171752 0.73 CA2 (0.71) CA2CA4CA5ATSHRPGK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0244167-B1 IMPROVED PROCESS FOR PREPARING POLY (ARYL ETHERS) AND POLY (ARYL ETHER KETONES) AMOCO CORPORATION (US) 1990-04-04 EP claimed
US-20260070025-A1 METHOD FOR OBTAINING A CATALYTIC MEMBRANE, CATALYTIC MEMBRANE OBTAINED AND USES THEREOF UNIV MURCIA (ES) 2026-03-12 US disclosed
US-20250133947-A1 Thermal Evaporation-Growth of Halide Perovskites Through Phosphonic Acid Addition GEORGIA TECH RES INST (US) 2025-04-24 US disclosed
EP-4442742-A1 METHOD FOR OBTAINING A CATALYTIC MEMBRANE, CATALYTIC MEMBRANE OBTAINED AND USES THEREOF Universidad de Murcia (ES) 2024-10-09 EP disclosed
WO-2024047264-A1 METHOD FOR OBTAINING A CATALYTIC MEMBRANE, CATALYTIC MEMBRANE OBTAINED AND USES THEREOF UNIVERSIDAD DE MURCIA (ES) 2024-03-07 WO disclosed
US-7943543-B1 Ionic liquid-solid-polymer mixed matrix membranes for gas separations UOP LLC (US) 2011-05-17 US disclosed
US-7635748-B2 Resin and article molded therefrom TORAY INDUSTRIES, INC. (JP) 2009-12-22 US disclosed
EP-1270646-B1 RESIN COMPOSITION AND ARTICLES MOLDED THEREFROM TORAY INDUSTRIES (JP) 2008-11-26 EP disclosed
US-7442757-B2 Resin, resin composition, method for manufacturing the same, and molded material including the same TORAY INDUSTRIES, INC. (JP) 2008-10-28 US disclosed
US-20080223785-A1 Ionic Polymer Membranes MILLER JEFFREY T 2008-09-18 US disclosed
WO-2006028529-A2 IONIC POLYMER MEMBRANES BP CORPORATION NORTH AMERICA INC. (US) 2006-03-16 WO disclosed
US-20060049102-A1 Ionic polymer membranes BP CORPORATION NORTH AMERICA INC. 2006-03-09 US disclosed
US-20060047104-A1 Resin, resin composition, process for production thereof, and moldings made by using the same TORAY INDUSTRIES, INC. (JP) 2006-03-02 US disclosed
CN-1649940-A Resin, resin compositions, process for production thereof, and moldings made by using the same TORAY INDUSTRIES (JP) 2005-08-03 CN disclosed
EP-1518884-A1 RESIN, RESIN COMPOSITIONS, PROCESS FOR PRODUCTION THEREOF, AND MOLDINGS MADE BY USING THE SAME TORAY INDUSTRIES, INC. (JP) 2005-03-30 EP disclosed
US-6750313-B2 HIGH REFRACTIVE INDEX AND LOW DISPERSION CHARACTERISTICS; OPTICAL LENSES, FILMS, DISCS; POLYCARBONATE RESIN CONTAINING A PHOSPHONIC ACID GROUP TORAY INDUSTRIES, INC. (JP) 2004-06-15 US disclosed
US-6579343-B2 Contacting gas with a liquid ionic compound comprising a nitrogen-containing heterocyclic cation UNIVERSITY OF NOTRE DAME DU LAC 2003-06-17 US disclosed
US-20030013836-A1 Resin composition and articles molded therefrom TORAY INDUSTRIES, INC., A CORPORATION OF JAPAN (JP) 2003-01-16 US disclosed
EP-1270646-A1 RESIN COMPOSITION AND ARTICLES MOLDED THEREFROM TORAY INDUSTRIES, INC. (JP) 2003-01-02 EP disclosed
US-20020189444-A1 Purification of gas with liquid ionic compounds NATIONAL SCIENCE FOUNDATION 2002-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260070025-A1 METHOD FOR OBTAINING A CATALYTIC MEMBRANE, CATALYTIC MEMBRANE OBTAINED AND USES THEREOF EMC2, PORCN, HAO2 MMP8 820/4885MMP14 2176/4885CA14 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.